In silico clinical trials of BiTE expression by oncolytic viruses reveal the impact of patient heterogeneity on dosage protocol.
Saved in:
| Title: | In silico clinical trials of BiTE expression by oncolytic viruses reveal the impact of patient heterogeneity on dosage protocol. |
|---|---|
| Authors: | Jenner, Adrianne L.1 (AUTHOR) adrianne.jenner@qut.edu.au, Araujo, Robyn P.2 (AUTHOR), Levi, Noa L.2 (AUTHOR), Ungerechts, Guy3,4,5 (AUTHOR), Engeland, Christine E.6 (AUTHOR), Heidbuechel, Johannes P. W.3,4 (AUTHOR) |
| Source: | PLoS Computational Biology. 7/30/2026, Vol. 22 Issue 7, p1-24. 24p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1553734X |
|---|---|
| DOI: | 10.1371/journal.pcbi.1014533 |
